HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salvatore Cuzzocrea Selected Research

xyloglucan

9/2021Evaluating the Protective Properties of a Xyloglucan-Based Nasal Spray in a Mouse Model of Allergic Rhinitis.
5/2020Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis.
1/2020Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study.
1/2018Protective Effects of Xyloglucan in Association with the Polysaccharide Gelose in an Experimental Model of Gastroenteritis and Urinary Tract Infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Salvatore Cuzzocrea Research Topics

Disease

254Inflammation (Inflammations)
05/2022 - 01/2002
68Spinal Cord Injuries (Spinal Cord Injury)
01/2019 - 10/2004
67Ischemia
06/2022 - 03/2002
60Shock
09/2020 - 03/2002
57Reperfusion Injury
09/2020 - 01/2002
56Edema (Dropsy)
10/2022 - 05/2002
52Pain (Aches)
05/2022 - 06/2004
40Colitis
02/2022 - 07/2002
40Necrosis
11/2020 - 01/2002
37Neuroinflammatory Diseases
07/2022 - 01/2011
36Lung Injury
10/2020 - 01/2002
36Body Weight (Weight, Body)
01/2020 - 10/2002
32Wounds and Injuries (Trauma)
04/2022 - 07/2002
32Pleurisy (Pleuritis)
01/2017 - 01/2002
31Myelitis
01/2014 - 02/2005
30Hyperalgesia
05/2022 - 06/2004
25Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2021 - 07/2002
24Pancreatitis
12/2020 - 05/2002
21Neoplasms (Cancer)
02/2022 - 06/2003
20Pneumonia (Pneumonitis)
07/2021 - 08/2003
20Multiple Organ Failure (MODS)
09/2011 - 10/2002
18Septic Shock (Toxic Shock Syndrome)
07/2011 - 11/2002
17Arthritis (Polyarthritis)
10/2022 - 10/2002
17Neurodegenerative Diseases (Neurodegenerative Disease)
07/2022 - 03/2005
17Traumatic Brain Injuries (Traumatic Brain Injury)
04/2022 - 11/2012
15Experimental Arthritis
10/2022 - 01/2002
15Parkinson Disease (Parkinson's Disease)
07/2022 - 09/2010
15Fibrosis (Cirrhosis)
04/2022 - 11/2006
15Weight Loss (Weight Reduction)
10/2020 - 07/2002
13Brain Injuries (Brain Injury)
06/2022 - 02/2011
11Alzheimer Disease (Alzheimer's Disease)
07/2022 - 09/2010
11Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2021 - 02/2006
11Neuralgia (Stump Neuralgia)
02/2021 - 05/2012
11Periodontitis
01/2018 - 06/2005
10Hypoxia (Hypoxemia)
07/2022 - 09/2004
10Hemorrhage
10/2021 - 05/2002

Drug/Important Bio-Agent (IBA)

71CytokinesIBA
05/2022 - 06/2002
62CarrageenanIBA
05/2022 - 01/2002
623-nitrotyrosineIBA
01/2018 - 05/2002
60palmidrolIBA
10/2021 - 09/2007
59Peroxidase (Myeloperoxidase)IBA
08/2021 - 02/2003
52Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 02/2003
39EnzymesIBA
04/2022 - 01/2002
37NF-kappa B (NF-kB)IBA
04/2022 - 01/2002
35Proteins (Proteins, Gene)FDA Link
07/2022 - 07/2002
35AntioxidantsIBA
05/2022 - 02/2002
35LigandsIBA
01/2014 - 07/2002
34Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2020 - 01/2002
32Peroxynitrous Acid (Peroxynitrite)IBA
12/2014 - 02/2002
31Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2021 - 07/2002
31ZymosanIBA
11/2013 - 01/2002
30DinitrobenzenesIBA
03/2021 - 07/2002
302,4-dinitrofluorobenzene sulfonic acidIBA
03/2021 - 07/2002
27Sulfonic AcidsIBA
03/2021 - 07/2002
27Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017 - 01/2002
27Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2016 - 01/2002
26Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 02/2002
25Pharmaceutical PreparationsIBA
01/2021 - 01/2005
24Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2021 - 01/2002
23Superoxides (Superoxide)IBA
04/2020 - 02/2002
23Transcription Factors (Transcription Factor)IBA
01/2019 - 01/2002
23PPAR alphaIBA
01/2010 - 07/2002
22Bleomycin (Blenoxane)FDA LinkGeneric
05/2022 - 05/2005
22LipopolysaccharidesIBA
01/2022 - 03/2003
21Superoxide DismutaseIBA
03/2020 - 06/2002
19CeruletideIBA
10/2020 - 05/2002
18Neuroprotective AgentsIBA
11/2020 - 02/2011
18MelatoninIBA
12/2019 - 02/2002
17Lipase (Acid Lipase)FDA Link
08/2020 - 05/2002
17AmylasesFDA Link
08/2020 - 05/2002
16P-SelectinIBA
01/2021 - 01/2002
15Interleukin-1beta (Interleukin 1 beta)IBA
08/2017 - 01/2002
14Analgesics (Analgesic Drugs)IBA
05/2022 - 11/2007
14Biological ProductsIBA
02/2022 - 01/2007
14PPAR gammaIBA
02/2009 - 05/2002
13Therapeutic UsesIBA
07/2020 - 05/2004
13Interleukin-6 (Interleukin 6)IBA
01/2020 - 06/2002
13ProstaglandinsIBA
01/2018 - 05/2002
13Poly Adenosine Diphosphate RiboseIBA
07/2011 - 08/2002
13DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2010 - 02/2005
12Collagen Type II (Type II Collagen)IBA
10/2022 - 10/2002
12LuteolinIBA
08/2021 - 01/2013
12Nitric Oxide Synthase (NO Synthase)IBA
01/2018 - 05/2002
12DNA (Deoxyribonucleic Acid)IBA
01/2017 - 01/2002
12CreatinineIBA
01/2013 - 08/2002
11Fatty Acids (Saturated Fatty Acids)IBA
03/2022 - 02/2008
11AcidsIBA
04/2021 - 07/2002
11GlucocorticoidsIBA
01/2012 - 11/2004
10Oxygen (Dioxygen)IBA
07/2022 - 02/2002
10CollagenIBA
04/2022 - 06/2005
102-pentadecyl-2-oxazolineIBA
01/2022 - 01/2016
10InflammasomesIBA
10/2021 - 01/2017
10Dexamethasone (Maxidex)FDA LinkGeneric
06/2021 - 06/2005
10Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2020 - 01/2004
10Malondialdehyde (Propanedial)IBA
07/2020 - 11/2002

Therapy/Procedure

64Therapeutics
05/2022 - 01/2002
38Laminectomy
01/2019 - 10/2004
23Intraperitoneal Injections
04/2022 - 05/2002
13Drug Therapy (Chemotherapy)
05/2021 - 08/2006
12Oral Administration
02/2021 - 08/2006